Introduction
Relations between respiratory symptoms and spirometric values remain a contentious issue, [1] [2] [3] [4] [5] [6] although a priori reasoning dictates that both symptoms and impaired lung function are different manifestations of sick lungs. Symptoms of chronic bronchitis, are very common. 1, 2 Very few of these subjects have chronic obstructive pulmonary diseases (COPD), 1, 2 and the presence of diagnosed asthma only partly explains these symptoms. 3 Typically, when COPD is diagnosed, a long course of structural and functional changes in the lungs has already occurred during many decades of life. When and how symptoms appear during the silent evolution of FEV 1 decline remains uncertain. [4] [5] [6] The part of this phenomenon explained by the presence of asthma also remains unknown. [7] [8] Some studies have shown that children 9 and adults 10 with asthma (or its intermediate phenotypes such as immunoglobulin E (IgE) levels or bronchial responsiveness 11 ) have a deficit in the maximum mid expiratory flow in comparison to subjects without asthma, 9-10 but others have come to different conclusions. [12] [13] The study of the relation between symptoms and lung function in representative samples of the general population may contribute to the interpretation of respiratory symptoms in an early, 'subclinical' stage of COPD (i.e., during youth and the first decades of adulthood) and, ultimately, to an understanding of its natural history. One difficulty in studying these relations is the multiple correlations between symptoms and the complexity of separating one from another. In a previous study with multiple respiratory symptoms, we demonstrated the benefit of using methods of exploratory factor analysis to group symptoms. 14 The European Community Respiratory Health Survey (ECRHS) is an international study of a general population sample, aged 20-44 years old, with cross-sectional information on respiratory symptoms and lung function, using a standard procedure in all centres. 15 This study permits investigation of the association between respiratory symptoms and lung function in an international context, with one aim being to describe relationships between symptoms and lung function taking into account the role of asthma and investigating both effect modification by sex and homogeneity between countries.
Subjects and methods
The protocol for the ECRHS has been described elsewhere. 15 Participating centres randomly selected at least 1500 men and 1500 women, aged 20-44 years. A 20% random sample of subjects were invited to answer a questionnaire on respiratory symptoms and risk factors, and to take part in blood tests, skin tests, and assessment of lung function by spirometry and airway challenge with methacholine. The overall response rate, with complete data for all of the questions and spirometry, was 47% (n ¼ 12; 541). Participants did not differ in terms of age, rates of smoking, or symptoms from non-participants. [14] [15] [16] The Institutional Review Board of the participating centres approved the study protocol and all participants gave informed written consent.
The questionnaire on symptoms and medical history was tested for comprehensibility and translated into all languages, with back translation into English. 12, 13 Baseline forced vital capacity (FVC) and maximal 1-s forced expiratory volume (FEV 1 ) were measured following a standard procedure including quality control. 15 Subjects were permitted nine attempts to provide at least two technically acceptable manoeuvres. Hyper-reactivity was defined as a 20% or greater fall in FEV 1 at the highest cumulative dose of methacoline, which was at 1 mg or an accumulated dose of 5.117 mmol of methacoline. Atopy was measured with specific IgE to common antigens and defined as positive if levels for any of the allergens were found to be higher than 0.35 KU/l. 15 Smoking definition was based on the questionnaire.
Descriptive statistics of the association of FEV 1 and, separately ratio FEV 1 /FVC with each symptom were made. In this analysis all centres were pooled, and subjects stratified by gender. The association between each of the symptoms and lung function indicators was estimated using multilevel (or hierarchical) models. 17 We first assessed the association between symptoms and lung function adjusted for height and age at individual level per each of the centres. Next, we assessed whether this association has a significant variance component between centres (heterogeneity of the effect). We classified subjects with FEV 1 /FVCo70% as having airflow obstruction. Among subjects without airflow obstruction, FEV 1 was treated as a continuous variable, in ml, which allowed us to assess smaller changes than if we had treated airflow obstruction as a dichotomous variable. The measure of association was defined as the odds ratio for having a FEV 1 /FVC ratio o70% and the linear regression coefficient for FEV 1 .
In addition to individual symptoms, a factor analysis was performed in order to use factors summarizing groups of symptoms. Factors were considered latent variables including a combination of symptoms. All respiratory symptoms in the ECRHS questionnaire were included in the factor analysis. Each symptom has a different weight in each factor according to the observed covariance among the symptoms. Factors were constructed using exploratory factor analysis without rotation. 18 In a previous analysis, we organized respiratory symptoms in the four factors 14 shown in Table 3 and entitled as: wheezing/shortness of breath, cough, hypersecretion and asthma. The latter is then defined as a combination of questions on having ever had asthma, attacks of asthma the last 12 months, having been confirmed by a doctor or having asthma treatment last 12 months. Factors were scaled in order to range from a minimum of 0 (people not having any of the symptoms in the factor) to a maximum of 1 (most severe combination of symptoms). Thus, in the context of this study, factors incorporate the intensity of symptoms, and are not considered a simple dichotomous variable. The use of factors allowed for separation of independent associations among a combination of symptoms and lung function from the other combinations of symptoms using multivariate modelling including all factors. Given the high correlation among respiratory symptoms, a multivariate analysis including the observed respiratory symptoms instead of the factors would not permit isolation of the independent association of each symptom. Table 1 describes the study participants, grouped by gender. It is important to note the high prevalence of smokers, regardless of gender. Across all symptoms, participants reporting a symptom's presence had lower FEV 1 than those not reporting the same symptom (Table 2 ). Crude differences between the presence and absence of each of the symptoms were larger in males than females for FEV 1 , but not for the FEV 1 /FVC ratio ( Table 2) . Questions on wheezing/shortness of breath (Q101, Q3, Q5) and on diagnosed asthma (Q1305, Q1306) were associated with the largest reduction in lung function and the greatest divergence between genders.
Results
All respiratory symptoms were found to be associated with airways obstruction (Table 3) . In order to include all symptoms in a multivariate model, factors combining symptoms were used. The strongest association with airflow obstruction was observed for the factor combining indicators of diagnosed asthma, followed by the factor combining symptoms of wheezing/shortness of breath ( Table 3 ). The independent association of the factor indicating the combination of symptoms of wheezing/shortness of breath with the ratio FEV 1 / FVC, after adjusting for the other factors, was statistically significant and similar in both genders. The fact that the strength of the odds ratios of the factors on diagnosed asthma and wheezing/shortness of breath decreased after including them in the same multivariate model is the result of a residual correlation between the factors. However, correlation between asthma and wheezing/shortness of breath could not explain an independent, and statistically significant, association of each of those factors with FEV 1 in the multivariate model. The factor combining symptoms associated with chronic mucus hypersecretion was unrelated to FEV 1 /FVCo70% after adjusting for other factors, while there was still a significant association with the factor indicating symptoms of cough in men. When instead of using factors, all symptoms were included in a multivariate model, only a few symptoms remain in the final model due to its strong multiple correlation. Hence, only wheezing (Q1), chronic cough (Q7) and attacks of asthma (Q1305) showed an adjusted significant association with having a FEV 1 /FVCo70%, which provides a coherent finding with the analysis with factors, but loses part of the information provided by the remaining symptoms, since the goodness of fit of the model is lower. Heterogeneity among centres was not significant (P40:4). Very similar results were obtained when airways obstruction was defined as FEV 1 /FVCo75%.
ARTICLE IN PRESS
Among subjects with FEV 1 /FVCX70%, the factor combining symptoms of wheezing/shortness of breath showed the strongest association with FEV 1 both in males and females, even after adjusting for the factor representing diagnosed asthma (Table  4) . Factors derived from questions on cough or phlegm were not associated with FEV 1 in the multivariate model. Similar results were obtained after excluding subjects with a FVC predicted o100% or a FEV 1 predicted o80%. The inclusion of the factor combining symptoms of wheezing/ shortness of breath in the multivariate model increased the goodness of fit of the model on FEV 1 by 3.4% in men, and 2.7% in women. This was larger than the percent explained by smoking (in pack years)Fat around 1%. The adjusted association with the combination of questions referring to wheezing/shortness of breath was quite homogeneous among countries (P for heterogeneity ¼ 0.2) (Fig. 1) . Table 5 and Fig. 1 show associations stratified by a third variable (i.e., centre or smoking) in men and women combined. This is intended to emphasize the similarity of findings for the two genders and to avoid small numbers when increasing strata.
Among subjects without airways obstruction, the association between FEV 1 and the factor related to wheezing/shortness of breath was similar by smoking, atopy and age (P for interaction 40.35), and if any, larger among those without smoking, without atopy and older age (Table 5) . However, the association between the factor associated with diagnosed asthma and FEV 1 was only evident among atopics and not among non-atopics (Po0:05). Stratification by airway response to methacholine eliminated any association between FEV 1 in obstructed individuals and the factor associated with diagnosed asthma. By contrast, the association between the factor associated with diagnosed asthma and airflow obstruction (FEV 1 /FVCo70%) was not modified by any of these variables (P for interaction 40.75) (data not shown).
Discussion
Reporting symptoms of asthma, and to a lesser extent wheezing/shortness of breath, was associated with airflow obstruction (ratio FEV 1 / FVCo70%) in this young adult population. Among subjects without airflow obstruction, reporting symptoms of wheezing/shortness of breath was associated with FEV 1 levelsFindependent of asthma, and in an invariant way according to smoking, atopy, bronchial responsiveness and age. By contrast, symptoms of cough or hypersecretion were not associated with lung function after considering the symptoms of wheezing/shortness of breath and asthma. These findings were very similar in both genders, although the physiological differences in the lung function, and among all countries, and although the international differences in perception and report of symptoms including the word asthma.
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14 It should be noted that the present study refers to lung function level and not growth or decline. Non-response in ECRHS seems unlikely to bias present associations between symptoms and lung function. 19 The usefulness of this analysis in the clinical setting to diagnose COPD at early stages is, however, poor since the predictive value of symptoms on lung function was weak. In the epidemiological context, this study describes the relations between respiratory symptoms and lung function in the general population. The pathophysiological explanations of this agreement between symptoms and lung function are unknown. The fact that the association between the factor on wheezing/shortness of breath and level of FEV 1 was similar in smokers and non-smokers and in atopic as well as non-atopic subjects suggests that the underlying causes of the respiratory damage could not modify the association between these symptoms and lung function. Similarly, the remaining association between wheezing and FEV 1 after stratifying for bronchial responsiveness, as well as the lack of an effect modification, suggests the presence of mechanisms other than bronchial responsiveness. The fact that the association between wheezing and FEV 1 among subjects without airflow obstruction was invariant after excluding subjects with abnormal FVC (o100% of the predicted) indicates that these findings cannot be attributed entirely to a low vital capacity.
Breathlessness is an important symptom in COPD. Fletcher and Peto 7 found that breathlessness was the symptom most closely associated with loss of lung function over time, and, ultimately, to a negative prognosis. Whether or not breathlessness presents as a consequence of loss of lung function is not known with precision. Although the coexistence 
Factor breathless/wheezing composed by questions Q-Q5, factor cough by Q6-Q801, factor hypersecretion by Q9-Q1001 and factor asthma by Q13-Q1306. w Adjusted for all factors in the table and age, height and centre. z Po0:05 for factors. All symptoms had a univariate association with Po0:05:
of decreased FEV 1 and dyspnea does show a wide inter-individual variability 8 and women reported it more often (8%) than men (5%), we found a homogeneous association in both genders and in all centres among these young populations. This suggests that the association appears in the early stages of lung function decline, and does not seem to be explained by the presence of diagnosed asthma or bronchial hyper-reactivity, since it was found after adjusting for both asthma and bronchial hyper-reactivity. Therefore, breathlessness (with or without wheezing) in young subjects should be regarded as a symptom associated with poor lung function, and probably indicates an early effect of a disease that will appear more clearly later in life.
We also found an association between chronic cough and mucus hypersecretion, which disappeared after adjusting for symptoms of wheezing/ shortness of breath. This likely indicates that the association with chronic cough and hyperesecretion is due in large measure to a third variable such as symptoms of wheezing/shortness of breath. We confirmed this finding after using orthogonal factors (i.e., statistical modification of factors to avoid any correlation among them when used in the same multivariate model, data not shown). As a consequence, these results reinforce the extended belief that chronic cough and expectoration at a young age are minor disorders without any relevant impact on health status. Fletcher et al. 1 concluded that mucus hypersecretion and decreased FEV 1 were different entities, which agree with other studies. [2] [3] [4] However, some studies [5] [6] have found an association between mucus hypersecretion and both decline in FEV 1 and hospital admissions because of COPD, perhaps because these studies incorporated older people or did not adjust for other symptoms.
Among young adults in this study, asthma showed the strongest negative association with airflow obstruction. This could potentially be explained as a result of not including a bronchodilator test in the study, except that all subjects were studied at baseline levels. In addition, there is evidence that asthmatics have a fixed deficit in FEV 1 12 Falthough debate continues about whether or not asthmatics have a slower growth and a more rapid decline than non-asthmatics. 20, 21 When the results of subjects without airflow obstruction were stratified by a third variable, we found that the association Figure 1 Change in FEV 1 (in litres) and 95% confidence interval in relation to the factor combining symptoms of wheezing/shortness of breath among those without airways obstruction, after adjusting for age, sex, height and the factors combining symptoms of asthma, cough and hypersecretion.
between asthma and lung function was only present among those subjects with atopy, not among nonatopic subjects. However, an association was found between the factor on asthma and having a FEV 1 / FVCo70%, both among atopic and non-atopic subjects. This discrepancy between the association with the ratio FEV 1 /FVCo70% and changes in FEV 1 among subjects without airflow obstruction merits confirmation in longitudinal studies assessing lung function growth and decline, and may signal a more moderate impact of asthma on non-reversible lung function impairment among non-atopic asthmatics. Despite the fact that previous studies suggest that the effects of asthma on lung function growth vary by gender, 22, 23 we found, in general, a lack of difference between the genders in terms of the associations resulting from a lower FEV 1 . Only in the case of a FEV 1 /FVC ratio o70% did we observe a stronger association in men than women for the factor indicators of diagnosed asthmaFand even then the differences were not statistically significant. This may suggest that the finding of a lack of differences by sex in the association of the factor combining symptoms of wheezing/shortness of breath and airways obstruction could be more closely related to a differential use of the term 'asthma' as a diagnostic label than to a true difference between genders.
After excluding subjects with airflow obstruction, symptoms of wheezing and/or shortness of breath, which were highly prevalent despite the young age of the study participants, showed the strongest association with lower levels of lung function. The international homogeneity of this finding strengthens its validity. Underlying mechanisms of this association are unknown, as is its potential reversibility. Ultimately, however, these findings are useful for studies on respiratory damage of environmental causes because they suggest that symptoms of wheezing/shortness of breath are the best indicator of lung function impairment and could be used in general population studies to operatively define COPD at early stages. 
